WINZUMA

Glaxo Group Limited

Application Filed: 2019-03-07
Trademark Application Details
Trademark Logo WINZUMA
700
Live/Registered
REGISTERED
Research OneLook Acronym Finder
Serial Number79255629
Registration Number5905904
Mark Drawing Code4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Attorney NameMerilee J. Arevalo
Attorney Docket Number82770756
Law Office AssignedL10
Employee NameLORENZO, GEORGE M

Timeline

2019-03-07Application Filed
2019-08-27Published for Opposition
2019-11-12Location: PUBLICATION AND ISSUE SECTION
2019-11-12Status: Live/Registered
2019-11-12Trademark Registered
2019-11-12Transaction Date

Trademark Applicants & Owners

Owner: Glaxo Group Limited
Entity StatementLimited Company
Address980 Great West Road Brentford, Middlesex TW8 9GS GB
Legal Entity Type
Legal Entity State GB

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

Merilee J. Arevalo
GSK
LBP, 5.5A
5 Moore Drive
Research Triangle Park NC 27709-3398

Good, Services, and Codes

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines
GS0051Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines

Trademark Filing History

DescriptionDateEvent Coding
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB2019-03-281 SDRC M:
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2019-04-032 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER2019-04-033 DOCK D:Assigned to Examiner
NON-FINAL ACTION WRITTEN2019-04-054 CNRT R:Renewal
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW2019-04-065 RFCR E:E-Mail
APPLICATION FILING RECEIPT MAILED2019-04-096 MAFR O:Outgoing Correspondence
REFUSAL PROCESSED BY MPU2019-04-297 RFRR P:
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB2019-04-298 RFCS P:
REFUSAL PROCESSED BY IB2019-05-179 RFNT P:
TEAS RESPONSE TO OFFICE ACTION RECEIVED2019-07-1210 TROA I:Incoming Correspondence
ASSIGNED TO LIE2019-07-1811 ALIE A:Allowance for Publication
CORRESPONDENCE RECEIVED IN LAW OFFICE2019-07-1812 CRFA I:Incoming Correspondence
TEAS/EMAIL CORRESPONDENCE ENTERED2019-07-1813 TEME I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER2019-07-2414 CNSA O:Outgoing Correspondence
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2019-08-0715 NONP E:E-Mail
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB2019-08-0716 OP2R P:
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB2019-08-0717 OPNS P:
NOTIFICATION PROCESSED BY IB2019-08-2318 GPNX P:
PUBLISHED FOR OPPOSITION2019-08-2719 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2019-08-2720 NPUB E:E-Mail
REGISTERED-PRINCIPAL REGISTER2019-11-1221 R.PR A:Allowance for Publication
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB2020-02-1222 FICR P:
FINAL DISPOSITION PROCESSED2020-03-1023 FIMP P:
FINAL DISPOSITION NOTICE SENT TO IB2020-03-1024 FICS P:
FINAL DECISION TRANSACTION PROCESSED BY IB2020-05-1525 FINO P:

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed